About Pharming Group N.V.
Pharming Group N.V. is a global, commercial stage biopharmaceutical company developing innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs. The flagship of our portfolio is our recombinant human C1 esterase inhibitor (rhC1INH) franchise. C1INH is a naturally occurring protein that down regulates the complement and
contact cascades in order to control inflammation in affected tissues.
As part of Rare Disease Day, we are raising awareness of the signs and symptoms of the rare primary immunodeficiency APDS and the importance of genetic testing for diagnosis. Our goal is to ensure that people with APDS are aware of the
resources available to help them understand more about this disease.
The AllaboutAPDS website and social media channels were created to provide information and educational resources for patients and healthcare professionals.
As part of Rare Disease Day, we are grateful to share the story of Heather, a mother who describes her daughter’s nine-year journey to an APDS diagnosis.
COR-US-2022-0002